BioCentury
ARTICLE | Company News

Approvable letter for CCH's Metadate CD

March 16, 2001 8:00 AM UTC

Celltech (LSE:CCH; CLL) received an approvable letter from the FDA for its Metadate CD (formerly MR) methylphenidate extended-release capsules to treat Attention Deficit Hyperactivity Disorder (ADHD)....